Premium
Limitation to the use of the urinary S‐/R‐mephenytoin ratio in pharmacogenetic studies.
Author(s) -
Zhang Y.,
Blouin RA,
McNamara PJ,
Steinmetz J.,
Wedlund PJ
Publication year - 1991
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1991.tb05542.x
Subject(s) - mephenytoin , urine , metabolite , urinary system , pharmacogenetics , chemistry , pharmacology , chromatography , genotype , biology , medicine , biochemistry , gene
The reproducibility of the S‐/R‐mephenytoin ratio was examined in urines stored at ‐20 degrees C over 2 years. Large changes in this ratio were observed in some urine samples stored for only a few months under these conditions. The changes observed in the S‐/R‐mephenytoin ratio are attributed to the decomposition of an acid labile metabolite of S‐mephenytoin which is eliminated in the urine. The instability of this metabolite makes it desirable to process urine shortly after its collection in order to avoid inaccurate phenotype assignments based upon the urinary S‐/R‐mephenytoin ratio. If rapid processing of urines is impractical, additional methods are described for preventing improper phenotype assignment of subjects.